Detection of orientation-specific anti-gp120 antibodies by a new N-glycanase protection assay (Q44325907)

2 December 2017

title

Detection of orientation-specific anti-gp120 antibodies by a new N-glycanase protection assay (English)

1 reference

2 December 2017

Gram GJ

1

1 reference

2 December 2017

Bolmstedt A

2

1 reference

2 December 2017

Schønning K

3

1 reference

2 December 2017

Biller M

4

1 reference

2 December 2017

Hansen JE

5

1 reference

2 December 2017

Olofsson S

6

1 reference

2 December 2017

publication date

1 February 2002

1 reference

Acta Pathologica et Microbiologica Scandinavica

2 December 2017

published in

1 reference

2 December 2017

volume

110

1 reference

2 December 2017

issue

2

1 reference

2 December 2017

page(s)

123-131

1 reference

Host cell glycosylation of viral glycoproteins--a battlefield for host defence and viral resistance

2 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2002.100202.X

Spatial conformation of glycans and glycoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2002.100202.X

Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2002.100202.X

The antigenic structure of the HIV gp120 envelope glycoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2002.100202.X

An N-glycan within the human immunodeficiency virus type 1 gp120 V3 loop affects virus neutralization

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2002.100202.X

Identification of an N-linked glycan in the V1-loop of HIV-1 gp120 influencing neutralization by anti-V3 antibodies and soluble CD4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2002.100202.X

Loss of a single N-linked glycan allows CD4-independent human immunodeficiency virus type 1 infection by altering the position of the gp120 V1/V2 variable loops

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2002.100202.X

Rapid selection for an N-linked oligosaccharide by monoclonal antibodies directed against the V3 loop of human immunodeficiency virus type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2002.100202.X

Resistance to V3-directed neutralization caused by an N-linked oligosaccharide depends on the quaternary structure of the HIV-1 envelope oligomer

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2002.100202.X

Simplified procedure for fractionation and structural characterisation of complex mixtures of N-linked glycans, released from HIV-1 gp120 and other highly glycosylated viral proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2002.100202.X

Isolation of a T-Lymphotropic Retrovirus from a Patient at Risk for Acquired Immune Deficiency Syndrome (AIDS)

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2002.100202.X

Nucleotide sequence of the AIDS virus, LAV

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2002.100202.X

The origin of HIV-1 isolate HTLV-IIIB

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2002.100202.X

T4 positive human neoplastic cell lines susceptible to and permissive for HTLV-III

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2002.100202.X

Restricted expression of human T-cell leukemia--lymphoma virus (HTLV) in transformed human umbilical cord blood lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2002.100202.X

Infection of HTLV-III/LAV in HTLV-I-carrying cells MT-2 and MT-4 and application in a plaque assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2002.100202.X

Sensitive and rapid assay on MT-4 cells for detection of antiviral compounds against the AIDS virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2002.100202.X

HIV-1 Neutralizing Monoclonal Antibodies Induced by a Synthetic Peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2002.100202.X

Chemokine receptor polymorphism and autologous neutralizing antibody response in long-term HIV-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2002.100202.X

Site-specific N-glycosylation and oligosaccharide structures of recombinant HIV-1 gp120 derived from a baculovirus expression system

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2002.100202.X

Protection of neutralization epitopes in the V3 loop of oligomeric human immunodeficiency virus type 1 glycoprotein 120 by N-linked oligosaccharides in the V1 region.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2002.100202.X

Oligomeric modeling and electrostatic analysis of the gp120 envelope glycoprotein of human immunodeficiency virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2002.100202.X

Epitopes of human immunodeficiency virus type 1 (HIV-1) envelope glycoproteins recognized by antibodies in the sera of HIV-1-infected individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2002.100202.X

Antigenic implications of human immunodeficiency virus type 1 envelope quaternary structure: oligomer-specific and -sensitive monoclonal antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2002.100202.X

A group of V3 sequences from human immunodeficiency virus type 1 subtype E non-syncytium-inducing, CCR5-using variants are resistant to positive selection pressure

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2002.100202.X

Sensitivity of HIV-1 to neutralization by antibodies against O-linked carbohydrate epitopes despite deletion of O-glycosylation signals in the V3 loop

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2002.100202.X

7 January 2021

Inhibition of human immunodeficiency virus (HIV) infection in vitro by anticarbohydrate monoclonal antibodies: peripheral glycosylation of HIV envelope glycoprotein gp120 may be a target for virus neutralization

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2002.100202.X

7 January 2021

Selection for neutralization resistance of the simian/human immunodeficiency virus SHIVSF33A variant in vivo by virtue of sequence changes in the extracellular envelope glycoprotein that modify N-linked glycosylation.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2002.100202.X

7 January 2021

Probing the structure of the human immunodeficiency virus surface glycoprotein gp120 with a panel of monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2002.100202.X

7 January 2021

Safety and immunogenicity of HIV recombinant envelope vaccines in HIV-infected infants and children. National Institutes of Health-sponsored Pediatric AIDS Clinical Trials Group (ACTG-218)

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2002.100202.X

7 January 2021

10.1034/J.1600-0463.2002.100202.X

Identifiers

DOI

1 reference

release_ojes4rxw4rgftbxo5hwnsonnle

2 December 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/ojes4rxw4rgftbxo5hwnsonnle

24 November 2022

mapped directly with Wikidata item

1 reference